ATE557277T1 - Verfahren zur diagnose von endometriose mittels tfpi-2 protein - Google Patents

Verfahren zur diagnose von endometriose mittels tfpi-2 protein

Info

Publication number
ATE557277T1
ATE557277T1 AT04773337T AT04773337T ATE557277T1 AT E557277 T1 ATE557277 T1 AT E557277T1 AT 04773337 T AT04773337 T AT 04773337T AT 04773337 T AT04773337 T AT 04773337T AT E557277 T1 ATE557277 T1 AT E557277T1
Authority
AT
Austria
Prior art keywords
endometriosis
protein
tfpi
diagnosis
methods
Prior art date
Application number
AT04773337T
Other languages
English (en)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of ATE557277T1 publication Critical patent/ATE557277T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/364Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT04773337T 2003-09-24 2004-09-14 Verfahren zur diagnose von endometriose mittels tfpi-2 protein ATE557277T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50557203P 2003-09-24 2003-09-24
PCT/JP2004/013718 WO2005029089A2 (en) 2003-09-24 2004-09-14 Method of diagnosing ovarian endometriosis using tfpi-2 protein

Publications (1)

Publication Number Publication Date
ATE557277T1 true ATE557277T1 (de) 2012-05-15

Family

ID=34375581

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04773337T ATE557277T1 (de) 2003-09-24 2004-09-14 Verfahren zur diagnose von endometriose mittels tfpi-2 protein

Country Status (4)

Country Link
EP (1) EP1668371B1 (de)
JP (1) JP4603548B2 (de)
AT (1) ATE557277T1 (de)
WO (1) WO2005029089A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2747721C (en) 2008-12-19 2021-07-20 Baxter International Inc. Tfpi inhibitors and methods of use
RU2011140471A (ru) 2009-03-06 2013-04-20 Мотида Фармасьютикал Ко., Лтд. Способ диагностики эндометриоза и диагностический набор для эндометриоза
EP2547355B1 (de) 2010-03-19 2017-01-11 Baxalta GmbH Tfpi-hemmer und verwendungsverfahren dafür
JP6074676B2 (ja) * 2011-08-19 2017-02-08 公立大学法人横浜市立大学 組織因子経路阻害因子2(tfpi2)測定による卵巣明細胞腺癌の検査方法および検査薬
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
EP2827883B1 (de) 2012-03-21 2019-05-08 Baxalta GmbH Tfpi inhibitoren und deren verwendung
JP6737504B2 (ja) 2014-11-27 2020-08-12 公立大学法人横浜市立大学 卵巣明細胞腺癌の検査方法及び検査薬
EP4113119A4 (de) * 2020-02-26 2024-03-06 Public University Corporation Yokohama City University Verfahren und reagenz zum nachweis von malignen eierstocktumoren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024952A1 (en) * 2002-08-30 2004-03-25 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis

Also Published As

Publication number Publication date
WO2005029089A3 (en) 2005-06-02
WO2005029089A9 (en) 2006-05-04
EP1668371A2 (de) 2006-06-14
JP2007506965A (ja) 2007-03-22
EP1668371B1 (de) 2012-05-09
JP4603548B2 (ja) 2010-12-22
WO2005029089A2 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
EA202092087A1 (ru) Анализы для выявления нейродегенеративных заболеваний
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE60233949D1 (de) Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
ATE312351T1 (de) Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
WO2007016367A3 (en) Neoplastic disease-related methods, kits, systems and databases
RU2015116674A (ru) Способ диагностики или мониторинга почечной функции или диагностики почечной дисфункции
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
ATE473448T1 (de) Verfahren zur diagnose von herz-kreislauf- krankheiten
WO2005029089A3 (en) Method of diagnosing ovarian endometriosis using tfpi-2 protein
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
ATE354095T1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
ATE412180T1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
ATE476665T1 (de) Natriurethische peptide und plazenta- wachstumfaktor/löslicher vegf-rezeptor unterscheiden zwischen mit der plazenta verbundener herzdysfunktion und mit herzerkrankung verbundener herzdysfunktion
WO2019053117A8 (en) Pct and pro-adm as markers for monitoring antibiotic treatment
NZ590993A (en) Dual specificity phosphatase 1 protein (DUSP1) for diagnosis and prognosis of skin cancer
EP3839511A3 (de) Diagnose einer neurologischen erkrankung
ATE423321T1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika